Louisiana House Bill HB386

Louisiana 2020 Regular Session

• Introduced: 2/27/20
• Refer: 2/27/20
• Refer: 3/9/20

Caption

Adds to the set of debilitating conditions qualifying a patient for a recommendation of medical marijuana by a physician

Impact

The bill's approval would amplifying access to medical marijuana treatment across Louisiana by offering more flexibility to healthcare providers. It would enable patients suffering from conditions not explicitly listed in the current law to receive recommendations, thus promoting broader therapeutic options. This change is expected to benefit a more extensive range of patients who may experience debilitating symptoms without belonging to a traditionally recognized category.

Summary

House Bill 386, introduced by Representative James, aims to expand the scope of conditions that qualify a patient for medical marijuana recommendations. Under this bill, physicians will have the authority to recommend medical marijuana for any condition they identify as debilitating based on their medical expertise, thereby allowing them to exercise their professional judgment regarding patient care. This is a significant shift from the existing law that enumerates specific debilitating conditions, which include various severe disorders such as cancer, glaucoma, and PTSD.

Sentiment

The sentiment surrounding HB 386 appears to be largely positive among advocates for medical marijuana. Supporters argue that it helps patients by providing more inclusive access to treatment options that can alleviate suffering. However, there also exist concerns about potential overreach or misuse of the physician's discretion in recommending medical marijuana, which opponents may raise as a point of contention during discussions.

Contention

Notable points of contention revolve around the broad authority granted to physicians in determining what constitutes a debilitating condition. Critics might argue that this lack of specificity could lead to increased applications and potential misuse of medical marijuana prescriptions. Additionally, there may be ongoing debates concerning the implications for mental health treatment and the regulatory frameworks necessary to govern such broad recommendations.